Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Frontline will continue to be led by CEO Mitch Williams, and the current management team, who will remain significant investors in the company.